CHARTWELL INVESTMENT PARTNERS, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 159 filers reported holding HERON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.

Quarter-by-quarter ownership
CHARTWELL INVESTMENT PARTNERS, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$1,862,000
-23.1%
100,171
+1.1%
0.06%
-21.8%
Q1 2019$2,421,000
+87.1%
99,042
+98.6%
0.08%
+69.6%
Q4 2018$1,294,000
-54.6%
49,882
-44.6%
0.05%
-45.2%
Q3 2018$2,850,000
+21.8%
90,049
+49.5%
0.08%
+20.0%
Q2 2018$2,340,000
+26.6%
60,237
-10.0%
0.07%
+11.1%
Q1 2018$1,848,000
-49.5%
66,955
-66.9%
0.06%
-49.2%
Q4 2017$3,656,000
+56.2%
201,977
+39.3%
0.12%
+55.0%
Q3 2017$2,340,000144,9470.08%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders